Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal
centre (GC) B cell differentiation. FL represents~ 5% of all haematological neoplasms and …

Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …

Background Follicular lymphoma is a clinically and genetically heterogeneous disease, but
the prognostic value of somatic mutations has not been systematically assessed. We aimed …

Abstract Disease Overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Purpose The aim of the F2 study was to verify whether a prospective collection of data would
enable the development of a more accurate prognostic index for follicular lymphoma (FL) by …

Purpose To compare the long-term outcome of patients with previously untreated follicular
lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and …

Purpose Optimal therapy of follicular lymphoma (FL) is not defined. We analyzed a large
prospective cohort study to identify current demographics and patterns of care of FL in the …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Purpose The utility of [18F] fluorodeoxyglucose (FDG) positron emission tomography–
computed tomography (PET-CT) in assessing response at the end of induction therapy is …

Purpose: Tumor-associated macrophage (TAM) content predicts survival in follicular
lymphoma (FL) patients treated with chemotherapy. The aim of this study was to determine …